Medical Health & Life Science Research News

Detailed examination of Meniere’s disease market made available by top research firm

Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems.

- Agency -.

A Meniere’s Disease Market report diagnosis which comprise of hearing assessment, balance assessment, blood tests, imaging test, and others. Balance assessment is sub-segmented into Videonystagmography (VNG), Rotary-chair testing, Vestibular evoked myogenic potentials (VEMP) testing, posturography, video Head Impulse Test (vHIT), Electrocochleography (ECoG), and others.

The Global Meniere’s Disease Market report titled “Meniere’s Disease Market Research Report- Global Forecast Till 2023” is competitive analysis report summarizes historical and forecast revenue of the market segmented into medication, noninvasive therapies & procedures, middle ear injections, surgery, and others. Medication is sub-segmented into motion sickness medications, anti-nausea medications and others.

Get Sample Copy @ www.marketresearchfuture.com/sample_request/3991 .

- Agency -.

In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50.

This is a chronic disease but different treatments can help in minimizing the symptoms. The major causes of Meniere’s disease are allergies, abnormal immune response, genetic predisposition, viral infection, migraines, head trauma, and some others.

About 90-95% of the patients control their Meniere’s disease with medical management.

The prevalence and incidence of Meniere’s disease is increasing. According to the National Institute on Deafness and Other Communication Disorders, there are around 615,000 Americas who are suffering from Meniere’s disease.

This number is continuously growing every year. According to Massachusetts Eye and Ear (An international center for treatment and research and a teaching hospital of Harvard Medical School), approximately 60,000 new cases of this disease are diagnosed annually.

Companies are working on this disease by investing in research and new product development that can cure this disease. Top pharmaceutical companies like F.

Hoffmann-La Roche Ltd, Novartis AG and Pfizer Inc. are exploring new options for the treatment of Meniere’s disease.

These companies have already started clinical trials for this disease. US based company Otonomy Inc. raised USD 115 million in 2014 for clinical trials for drug that can quiet the overexcitement of the signaling between nerve cells in the cochlea that is linked to tinnitus.

Otonomy Inc. is also testing a steroid gel to treat Meniere’s disease.

Access report @ www.marketresearchfuture.com/check…mp;report_id=3991 .

Increasing awareness of this disorder is another important factor for the market growth. Some other factors such as technological advancement, introduction and rapid adoption of therapies are also leading the market growth.

Increasing demand from emerging markets of Asia and Latin America are creating smooth path for the market growth.  

The global Meniere’s disease market is growing moderately and is expected to continue its growth during the forecast period. Global Meniere’s disease market is expected to grow at the CAGR of ~5.4% during the forecast period and is estimated to reach USD 6380.3 million by 2023.

Key Players in the Global Meniere’s Disease Market: Auris Medical (Switzerland), Jubilant Cadista (US), Otonomy Inc.(US), Prestige Brands Holdings, Inc. (US), Sound Pharmaceuticals (US), The Ear Company (Canada), WellSpring Pharmaceutical Corporation (US) and others.

Considering the global scenario of the market, the Americas are the largest market for Meniere’s disease. The Americas mainly include North America and Latin America.

North America is the dominating region not only in Americas but also in global market. US is the top contributor in North America region.

Some major factors like investment in research and development, and technological advanced are driving the growth for the market. Europe is the second highest revenue generating region in global Meniere’s disease market.

Europe is mainly divided into Eastern Europe and Western Europe. More developed countries of Western Europe like Germany, France and UK are holding major market share while the East European countries are also growing significantly.

Due to developing healthcare infrastructure, increasing awareness, increasing healthcare expenditure, and growing adoption of new devices and treatment options, Asia Pacific region is the fastest growing in global Meniere’s disease market. Middle East & Africa is expected to grow slower than the global average.

Middle Eastern countries like UAE and Saudi are dominating this market; it is mainly due to availability of top class medical facilities, high income and government support to improve public health.

Access report @ www.marketresearchfuture.com/check-discount/3991 .

Major TOC for Meniere’s Disease Market:

Research methodology

Market dynamics

Market factor analysis

Global Meniere’s Disease market, by type

Global Meniere’s Disease market, by technology

Global Meniere’s Disease market, by end user

Global Meniere’s Disease market, by region

Competitive landscape

News From

Market Research Future - Industry Analysis Report & Business ResearchMarket Research Future
Category: Market Research Publishers and RetailersCompany profile: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.